FFNT:CA:CNSX-4Front Ventures Corp (CAD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 0.07

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona. Address: 7010 East Chauncey Lane, Phoenix, AZ, United States, 85054

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
GTII:CA Green Thumb Industries Inc

-0.04 (-0.25%)

USD 3.28B
TRUL:CA Trulieve Cannabis Corp

-0.07 (-0.43%)

USD 2.92B
CL:CA Cresco Labs Inc

-0.02 (-0.90%)

USD 0.77B
AYR-A:CA Ayr Wellness Inc

+0.01 (+0.41%)

USD 0.28B
PLTH:CA Planet 13 Holdings Inc

N/A

USD 0.26B
GRIN:CA Grown Rogue International Inc

+0.03 (+3.23%)

USD 0.21B
AAWH-U:CA Ascend Wellness Holdings Inc.

-0.02 (-2.50%)

USD 0.17B
JUSH:CA Jushi Holdings Inc

+0.06 (+9.23%)

USD 0.13B
IAN:CA iAnthus Capital Holdings Inc

+0.01 (+50.00%)

USD 0.10B
MRMD:CA MariMed Inc.

N/A

USD 0.09B

ETFs Containing FFNT:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -46.15% 26% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -46.15% 26% F 34% F
Trailing 12 Months  
Capital Gain -41.67% 38% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.67% 38% F 42% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -40.98% N/A N/A 7% C-
Dividend Return -40.98% N/A N/A 7% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.18% N/A N/A 85% B
Risk Adjusted Return -140.44% N/A N/A 3% F
Market Capitalization 0.06B 85% B 96% N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector